A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Anoushka P. Lal, Yi Chao Foong, Paul G. Sanfilippo, Tim Spelman, Louise Rath, David Levitz, Marzena Fabis-Pedrini, Matteo Foschi, Mario Habek, Tomas Kalincik, Izanne Roos, Jeannette Lechner-Scott, Nevin John, Aysun Soysal, Emanuele D’Amico, Riadh Gouider, Saloua Mrabet, Katrin Gross-Paju, Simón Cárdenas-Robledo, Abdorreza Naser MoghadasiMaria Jose Sa, Orla Gray, Jiwon Oh, Stephen Reddel, Sudarshini Ramanathan, Talal Al-Harbi, Ayse Altintas, Todd A. Hardy, Serkan Ozakbas, Raed Alroughani, Allan G. Kermode, Andrea Surcinelli, Guy Laureys, Sara Eichau, Alexandre Prat, Marc Girard, Pierre Duquette, Suzanne Hodgkinson, Cristina Ramo-Tello, Davide Maimone, Pamela McCombe, Daniele Spitaleri, Jose Luis Sanchez-Menoyo, Mehmet Fatih Yetkin, Seyed Mohammad Baghbanian, Rana Karabudak, Abdullah Al-Asmi, Gregor Brecl Jakob, Samia J. Khoury, Masoud Etemadifar, Vincent van Pesch, Katherine Buzzard, Bruce Taylor, Helmut Butzkueven, Anneke Van der Walt
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic'. Together they form a unique fingerprint.